SHSE:600299

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Bluestar Adisseo Company engages in the research, development, production, and sale of feed additives for animal nutrition worldwide. More Details


Snowflake Analysis

Excellent balance sheet, good value and pays a dividend.


Similar Companies

Share Price & News

How has Bluestar Adisseo's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 600299 is not significantly more volatile than the rest of CN stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: 600299's weekly volatility (6%) has been stable over the past year.


Market Performance


7 Day Return

-6.5%

600299

-1.7%

CN Chemicals

-0.1%

CN Market


1 Year Return

21.9%

600299

40.8%

CN Chemicals

19.1%

CN Market

Return vs Industry: 600299 underperformed the CN Chemicals industry which returned 40.8% over the past year.

Return vs Market: 600299 exceeded the CN Market which returned 19.1% over the past year.


Shareholder returns

600299IndustryMarket
7 Day-6.5%-1.7%-0.1%
30 Day4.4%-3.0%-1.8%
90 Day9.4%10.2%0.7%
1 Year23.4%21.9%42.9%40.8%21.0%19.1%
3 Year7.3%1.8%27.6%22.4%24.1%18.0%
5 Year0.4%-7.7%59.1%50.1%46.7%36.7%

Long-Term Price Volatility Vs. Market

How volatile is Bluestar Adisseo's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Bluestar Adisseo undervalued compared to its fair value and its price relative to the market?

3.2%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: 600299 (CN¥13.6) is trading below our estimate of fair value (CN¥14.05)

Significantly Below Fair Value: 600299 is trading below fair value, but not by a significant amount.


Price To Earnings Ratio

PE vs Industry: 600299 is good value based on its PE Ratio (28.3x) compared to the CN Chemicals industry average (36.3x).

PE vs Market: 600299 is good value based on its PE Ratio (28.3x) compared to the CN market (34.7x).


Price to Earnings Growth Ratio

PEG Ratio: 600299 is poor value based on its PEG Ratio (3x)


Price to Book Ratio

PB vs Industry: 600299 is good value based on its PB Ratio (2.7x) compared to the CN Chemicals industry average (2.8x).


Next Steps

Future Growth

How is Bluestar Adisseo forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

9.4%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 600299's forecast earnings growth (9.4% per year) is above the savings rate (3.3%).

Earnings vs Market: 600299's earnings (9.4% per year) are forecast to grow slower than the CN market (24.8% per year).

High Growth Earnings: 600299's earnings are forecast to grow, but not significantly.

Revenue vs Market: 600299's revenue (11.8% per year) is forecast to grow slower than the CN market (18.1% per year).

High Growth Revenue: 600299's revenue (11.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 600299's Return on Equity is forecast to be low in 3 years time (11.9%).


Next Steps

Past Performance

How has Bluestar Adisseo performed over the past 5 years?

-16.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 600299 has high quality earnings.

Growing Profit Margin: 600299's current net profit margins (10.9%) are higher than last year (9.2%).


Past Earnings Growth Analysis

Earnings Trend: 600299's earnings have declined by 16.4% per year over the past 5 years.

Accelerating Growth: 600299's earnings growth over the past year (24.4%) exceeds its 5-year average (-16.4% per year).

Earnings vs Industry: 600299 earnings growth over the past year (24.4%) exceeded the Chemicals industry 5.2%.


Return on Equity

High ROE: 600299's Return on Equity (9.4%) is considered low.


Next Steps

Financial Health

How is Bluestar Adisseo's financial position?


Financial Position Analysis

Short Term Liabilities: 600299's short term assets (CN¥7.2B) exceed its short term liabilities (CN¥3.2B).

Long Term Liabilities: 600299's short term assets (CN¥7.2B) exceed its long term liabilities (CN¥1.4B).


Debt to Equity History and Analysis

Debt Level: 600299's debt to equity ratio (4.4%) is considered satisfactory.

Reducing Debt: 600299's debt to equity ratio has increased from 0.06% to 4.4% over the past 5 years.

Debt Coverage: 600299's debt is well covered by operating cash flow (444.2%).

Interest Coverage: 600299 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is Bluestar Adisseo current dividend yield, its reliability and sustainability?

2.29%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 600299's dividend (2.29%) is higher than the bottom 25% of dividend payers in the CN market (0.4%).

High Dividend: 600299's dividend (2.29%) is in the top 25% of dividend payers in the CN market (1.76%)


Stability and Growth of Payments

Stable Dividend: 600299 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: 600299's dividend payments have increased, but the company has only paid a dividend for 5 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (32.5%), 600299's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: 600299's dividends in 3 years are forecast to be covered by earnings (59.8% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.4yrs

Average board tenure


CEO

Jean-Marc Dublanc (66 yo)

no data

Tenure

CN¥9,700,000

Compensation

Mr. Jean-Marc Dublanc is Vice Chairman of the Board at Bluestar Adisseo Company. He serves as General Manager of Blue Star New Chemical Materials Co., Ltd. Mr. Dublanc has been the Chief Executive Officer ...


Board Members

NamePositionTenureCompensationOwnership
Jean-Marc Dublanc
Vice Chairman of the Board & GMno dataCN¥9.70mno data
Dengjie Gu
Deputy GM & Director2.42yrsCN¥3.39mno data
Gérard Deman
Directorno datano datano data
Jean Falgoux
Independent Director5.42yrsCN¥200.00kno data
Lixin Song
Independent Director5.42yrsCN¥200.00kno data
Yuan Ding
Independent Director2.42yrsCN¥200.00kno data
Zhigang Hao
Chairman2.42yrsno datano data
Yan Wang
Chairman of Board of Supervisors2.42yrsno datano data
Wei Lu
Member of Board of Supervisors2.42yrsno datano data
Yong Pan
Member of Board of Supervisors2.42yrsno datano data
Yougen Ge
Director2.42yrsno datano data
Jingwan Wu
Director1.17yrsno datano data

2.4yrs

Average Tenure

51yo

Average Age

Experienced Board: 600299's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Bluestar Adisseo Company's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Bluestar Adisseo Company
  • Ticker: 600299
  • Exchange: SHSE
  • Founded: 1939
  • Industry: Commodity Chemicals
  • Sector: Materials
  • Market Cap: CN¥36.474b
  • Shares outstanding: 2.68b
  • Website: https://www.bluestar-adisseo.com

Number of Employees


Location

  • Bluestar Adisseo Company
  • 9 West Beitucheng Road
  • Chaoyang District
  • Beijing
  • 100029
  • China

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
600299SHSE (Shanghai Stock Exchange)YesDomestic SharesCNCNYOct 2015
600299XSSC (Shanghai Stock Exchange - Shanghai - Hong Kong Stock Connect)YesDomestic SharesCNCNYOct 2015

Biography

Bluestar Adisseo Company engages in the research, development, production, and sale of feed additives for animal nutrition worldwide. The company’s products include Rhodimet, a methionine solution for mono...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/03/07 09:09
End of Day Share Price2021/03/05 00:00
Earnings2020/09/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.